pre-IPO PHARMA

COMPANY OVERVIEW

Phoenix Biotechnology, Inc. is a San Antonio-based company specializing the development of Nerium oleander-based drugs used in the treatment of cancer, neurodegenerative diseases, and certain viruses.


LOCATION

  • San Antonio, TX, USA

  • THERAPEUTIC AREAS

  • Infectious Disease
  • Neurological DIsorders
  • Oncology

  • WEBSITE

    https://www.phoenixbiotechnology.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Mar 17, 2021

    New Study Presents Evidence of Effectiveness and Safety Of Oleandrin and Phoenix Biotechnology’s PBI-06150 Against SARS-CoV-2


    Dec 11, 2019

    Phoenix Biotechnology Announces Completion of Private Placement


    For More Press Releases


    Google Analytics Alternative